Fiore Cannabis Ltd. (FIORF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Fiore Cannabis Ltd. (FIORF) trades at $0.00 with AI Score 55/100 (Grade B). Fiore Cannabis Ltd. cultivates, produces, and distributes medical and recreational marijuana in the United States. Market cap: $1,971, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for FIORF: FIORF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates FIORF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
FIORF: the 6 perspectives are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →Fiore Cannabis Ltd. (FIORF) Healthcare & Pipeline Overview
Fiore Cannabis Ltd. operates in the U.S. cannabis market, focusing on cultivation, production, and distribution of medical and recreational marijuana. The company also runs a dispensary in California, integrating both upstream and downstream operations within a competitive and evolving regulatory landscape.
What Is the Investment Thesis for FIORF?
Fiore Cannabis Ltd. presents a speculative investment opportunity within the evolving U.S. cannabis market. The company's vertical integration, encompassing cultivation, production, and retail through its California dispensary, offers potential for margin capture across the value chain. However, the company's negative profit margin of -280.9% indicates significant operational challenges. Key catalysts include potential regulatory changes in the U.S. that could expand market access. Investors should closely monitor the company's ability to improve profitability and manage its operations effectively. The company's beta of 0.83 suggests lower volatility compared to the overall market. The absence of a dividend reflects its focus on reinvesting earnings for growth. The market capitalization of 2K indicates that it is a micro-cap stock.
Based on FMP financials and quantitative analysis
FIORF Key Highlights
- Operates in the U.S. medical and recreational cannabis market.
- Vertically integrated with cultivation, production, and retail operations.
- Gross margin of 22.6% indicates potential for profitability improvements.
- Negative profit margin of -280.9% reflects current operational challenges.
- Beta of 0.83 suggests lower volatility compared to the market.
Who Are FIORF's Competitors?
FIORF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| NPNKF Nippon Shinyaku Co., Ltd. | $31.40 | +0.00% | $2.12B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FIORF's Key Strengths?
- Vertically integrated operations.
- Dispensary in California.
- Focus on both medical and recreational markets.
What Are FIORF's Weaknesses?
- Negative profit margin.
- Limited geographic presence.
- Small market capitalization.
What Could Drive FIORF Stock Higher?
- Potential changes in U.S. federal cannabis regulations could expand market access and reduce regulatory burdens.
- Expansion of operations into new states as cannabis legalization progresses.
- Development and launch of new cannabis-infused products to meet evolving consumer demand.
- Strategic partnerships and acquisitions to enhance capabilities and market reach.
What Are the Key Risks for FIORF?
- Financial-distress signal — its Altman Z-Score of -11.63 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition in the cannabis industry could pressure margins and limit market share.
- Fluctuations in cannabis prices could impact revenue and profitability.
- Changes in state and local regulations could create compliance challenges and increase costs.
- Limited access to capital could constrain growth opportunities.
- Negative profit margin indicates operational inefficiencies.
What Are the Growth Opportunities for FIORF?
- Expansion into New Markets: Fiore Cannabis can explore opportunities to expand its operations into additional states as cannabis legalization progresses across the U.S. This includes states with established medical cannabis programs and those considering recreational legalization. Entering new markets would require navigating different regulatory frameworks and establishing local partnerships. The U.S. cannabis market is projected to reach $40 billion by 2030, offering significant growth potential for companies that can successfully expand their geographic footprint. Timeline: Ongoing.
- Product Innovation and Development: Fiore Cannabis can invest in research and development to create new and innovative cannabis products, such as edibles, concentrates, and topicals. This includes developing products with specific cannabinoid profiles and formulations to target different consumer needs and preferences. The market for cannabis-infused products is growing rapidly, driven by increasing consumer interest in alternative consumption methods. By developing differentiated products, Fiore Cannabis can enhance its brand reputation and attract new customers. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Fiore Cannabis can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This includes partnering with other cannabis companies, technology providers, and distribution networks. Acquisitions can provide access to new markets, technologies, and product lines. Strategic partnerships can help Fiore Cannabis leverage the expertise and resources of other companies to accelerate its growth. Timeline: Ongoing.
- Optimization of Cultivation and Production Processes: Fiore Cannabis can focus on optimizing its cultivation and production processes to improve efficiency and reduce costs. This includes implementing advanced cultivation techniques, such as hydroponics and vertical farming, to maximize yields and minimize resource consumption. By improving its operational efficiency, Fiore Cannabis can enhance its profitability and competitiveness. Timeline: Ongoing.
- Enhancement of Retail Operations: Fiore Cannabis can enhance its retail operations by improving the customer experience and expanding its product offerings. This includes creating a welcoming and informative retail environment, providing personalized customer service, and offering a wide range of cannabis products and accessories. By enhancing its retail operations, Fiore Cannabis can attract and retain customers, increase sales, and build brand loyalty. Timeline: Ongoing.
What Opportunities Does FIORF Have?
- Expansion into new states.
- Development of new cannabis products.
- Strategic partnerships and acquisitions.
What Threats Does FIORF Face?
- Changing regulations.
- Intense competition.
- Fluctuations in cannabis prices.
What Are FIORF's Competitive Advantages?
- Vertical integration provides control over the supply chain.
- Dispensary operations provide direct access to consumers.
- Brand recognition in the California market.
What Does FIORF Do?
Fiore Cannabis Ltd., formerly known as Citation Growth Corp., rebranded in October 2020 to reflect its focus on the cannabis industry. Incorporated in 2007 and headquartered in Kelowna, Canada, the company cultivates, produces, and distributes medical and recreational marijuana in the United States. Fiore Cannabis operates a dispensary in California, allowing it to directly serve consumers. The company's operations span the entire value chain, from cultivation to retail, positioning it as a vertically integrated player in the cannabis market. Fiore Cannabis aims to capitalize on the growing demand for cannabis products in the U.S., navigating the complex regulatory environment to establish a strong market presence. The company's strategy involves optimizing its cultivation and production processes to ensure high-quality products and efficient operations. By focusing on both medical and recreational markets, Fiore Cannabis seeks to diversify its revenue streams and cater to a broad customer base.
What Products and Services Does FIORF Offer?
- Cultivates medical marijuana.
- Cultivates recreational marijuana.
- Produces medical marijuana products.
- Produces recreational marijuana products.
- Distributes medical marijuana products.
- Distributes recreational marijuana products.
- Operates a dispensary in California.
How Does FIORF Make Money?
- Cultivation and production of cannabis.
- Distribution of cannabis products to dispensaries.
- Retail sales through its own dispensary.
What Industry Does FIORF Operate In?
Fiore Cannabis Ltd. operates within the rapidly expanding U.S. cannabis industry. The market is characterized by increasing legalization, evolving regulations, and growing consumer demand for both medical and recreational cannabis products. The industry is highly competitive, with numerous players vying for market share. Key trends include the consolidation of smaller companies, the development of new cannabis-infused products, and the increasing focus on quality and branding. Fiore Cannabis competes with other cannabis producers and retailers, including CBGI, HCANF, LOWLF, MDIT, and MDXL, all of whom are navigating similar regulatory and market dynamics.
Who Are FIORF's Key Customers?
- Medical marijuana patients in the U.S.
- Recreational cannabis users in the U.S.
- Dispensaries in California.
Company Profile
Fiore Cannabis Ltd. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Kelowna, CA. The company is led by CEO Erik Anderson. FIORF has traded publicly since 2015.
F-Score 3/9Financial Health
Fiore Cannabis Ltd.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -11.63 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on assets is -50.7%, showing how much profit it generates from its asset base. A current ratio of 0.25 means current liabilities exceed short-term assets, a liquidity point worth watching.
FIORF Valuation & Market Position
With a 2K market cap, Fiore Cannabis Ltd. sits in the micro-cap segment of the market. Relative to its peer group, FIORF's quantitative score of 55/100 is below the peer average of 66/100.
FIORF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Vertically integrated operations.
- Dispensary in California.
- Focus on both medical and recreational markets.
- Upcoming: Potential changes in U.S. federal cannabis regulations could expand market access and reduce regulatory burdens.
Bear Case
- Negative profit margin.
- Limited geographic presence.
- Small market capitalization.
- Ongoing: Intense competition in the cannabis industry could pressure margins and limit market share.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
FIORF Latest News
No recent news available for FIORF.
FIORF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FIORF.
Price Targets
Wall Street price target analysis for FIORF.
FIORF MoonshotScore
What does this score mean?
The MoonshotScore rates FIORF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Erik Anderson
CEO
Erik Anderson serves as the CEO of Fiore Cannabis Ltd. His background includes experience in the cannabis industry, with a focus on operations and business development. He has been involved in various aspects of the cannabis value chain, from cultivation to retail. Anderson's expertise lies in navigating the complex regulatory landscape and building sustainable business models in the cannabis sector. He is committed to driving growth and innovation at Fiore Cannabis.
Track Record: Under Erik Anderson's leadership, Fiore Cannabis Ltd. has focused on expanding its operations in the U.S. cannabis market. Key milestones include the rebranding of the company and the optimization of its cultivation and production processes. Anderson has also overseen the development of new cannabis products and the enhancement of the company's retail operations. His strategic decisions have aimed at improving the company's profitability and competitiveness.
FIORF OTC Market Information
The OTC Other tier, also known as the Pink Sheets, represents the lowest tier of the over-the-counter (OTC) market. Companies listed on this tier typically do not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB, or major exchanges like NYSE or NASDAQ. This tier is often populated by speculative or distressed companies, and may include companies with limited operating history or those that are thinly traded. Investing in companies on the OTC Other tier carries significant risks due to the lack of regulatory oversight and transparency.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Lack of regulatory oversight.
- Speculative nature of the business.
- Verify the company's legal standing and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive position.
- Evaluate the management team's experience and track record.
- Understand the regulatory environment and potential risks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Operation of a dispensary in California.
- Focus on both medical and recreational markets.
- Rebranding efforts to focus on the cannabis industry.
FIORF Healthcare Stock FAQ
What does Fiore Cannabis Ltd. do?
Fiore Cannabis Ltd. cultivates, produces, and distributes medical and recreational marijuana in the United States. The company operates a dispensary in California, providing direct access to consumers. Fiore Cannabis focuses on both the upstream (cultivation and production) and downstream (retail) aspects of the cannabis value chain. This vertical integration allows the company to capture margins at multiple stages and potentially improve profitability. The company's strategy involves expanding its product offerings and geographic reach to capitalize on the growing cannabis market.
What do analysts say about FIORF stock?
As of 2026-03-17, there is no readily available analyst coverage for FIORF stock due to its OTC listing and small market capitalization. Investors should conduct their own thorough research and due diligence before investing in FIORF. Key valuation metrics, such as price-to-earnings ratio, are not meaningful due to the company's negative earnings. Growth considerations include the potential for market expansion and product innovation, but these are subject to regulatory and competitive risks. The speculative nature of the stock warrants caution.
What are the main risks for FIORF?
The main risks for Fiore Cannabis Ltd. include intense competition in the cannabis industry, which could pressure margins and limit market share. Fluctuations in cannabis prices could impact revenue and profitability. Changes in state and local regulations could create compliance challenges and increase costs. Limited access to capital could constrain growth opportunities. The company's negative profit margin indicates operational inefficiencies that need to be addressed. As an OTC-listed stock, FIORF is subject to additional risks related to liquidity, disclosure, and regulatory oversight.
What are the key factors to evaluate for FIORF?
Fiore Cannabis Ltd. (FIORF) holds an AI score of 55/100 (moderate). Not financial advice.
How frequently does FIORF data refresh on this page?
FIORF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven FIORF's recent stock price performance?
Fiore Cannabis Ltd. (FIORF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider FIORF overvalued or undervalued right now?
Valuing Fiore Cannabis Ltd. (FIORF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying FIORF?
Before investing in Fiore Cannabis Ltd. (FIORF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited due to the company's OTC listing.
- Analyst coverage is unavailable.
- The cannabis industry is subject to rapid regulatory changes.